Abstract:Objective To investigate the clinical efficacy and safety of endoscopic selective varies devascularization (ESVD) combined with esophageal variceal sclerosis (EIS) in treatment of esophageal and gastric varices.Methods 260 patients with hepatic sclerosis complicated with esophageal and gastric varices rupture and bleeding were selected. According to different treatment methods, they were divided into three groups: esophageal variceal ligation treatment group (EVL group), esophageal variceal sclerotherapy treatment group (EIS group) and combined treatment group (ESVD combined EIS group). After two years follow-up, the improvement rate of varicose veins (after three months), the rate of early rebleeding (within two weeks), the rate of delayed rebleeding (within three months), the total rebleeding rate (within 2 years), the occurrence of complications and the treatment cost were compared.Results The improvement rate of varicose veins in the three groups was compared: the total improvement rate was 93.5% (243/260), and the combined treatment group was higher than that the other two groups (P < 0.05); Compared the early rebleeding rate of three groups, there was no significant difference among the three groups (P > 0.05), the delayed rebleeding rate and the total rebleeding rate in combined treatment group were lower than those in other two groups (P < 0.05); None of the three groups had ectopic embolism, incidence rate of postoperative fever in combined treatment group was significantly higher than that in other two groups (P < 0.05), the postoperative pain in the ligation treatment group was higher than that in other two groups (P < 0.05); The treatment cost in combined treatment group was significantly higher than that in the other two groups (P < 0.05).Conclusion ESVD combined with EIS therapy could be effective for esophageal-gastric varicose. The incidence of complications was not significantly increased, but the cost of treatment may be high.